The issuance would include refunding all or part of a bond series totaling about $1.4 billion, as well as issuing about $300 million of tax-exempt bonds, according to a municipal bond filing.
The filing states that the $300 million would be issued to cover the cost of “the acquisition, construction, renovation and equipping of new and existing Trinity Health facilities or refinancing such expenditures.”
As far as refunding the $1.4 billion in bonds, Trinity Health said the health system is considering refinancing opportunities which would reduce interest costs and provide significant savings to Trinity Health and its member entities.
“These refinancing opportunities are market-dependent and, if pursued, are required to be refinanced with taxable debt,” the health system said.
More articles on healthcare finance:
Fee-for-service payments still account for most physician practice revenue, AMA finds
Insurers are to blame for surprise medical bills, physician-staffing company exec says
CMS price transparency effort falls short, Nebraska hospital CFOs say
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
